
Ju Dong Yang, MD, MSc, discusses patients with nonalcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) who present without cirrhosis at the time of diagnosis of liver cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: September 14th 2016 | Updated: